Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 5, 2011Journal of Clinical OncologyOpen Access

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

View Full Paper
Ask AI
Bookmark
Share

Authors

Tiziano BarbuiTiziano BarbuiUniversity of BergamoGBGiovanni BarosiFoundation CenterGBGunnar BirgegårdUppsala University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Barbui et al. (2011) studied this question.

synapsesocial.com/papers/6a10282dd13714ec96ff4741https://doi.org/10.1200/jco.2010.31.8436
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden2008 · 261 citations
  2. 2Transfusion‐dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis—prognostic relevance is independent of IPSS or karyotype2009 · 78 citations
  3. 3Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia2008 · 185 citations
  4. 4Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long‐term follow‐up of a randomized clinical trial2000 · 217 citations
  5. 5PEG‐IFN‐α‐2a therapy in patients with myelofibrosis2009 · 66 citations